STMM
UTHR icon

South Texas Money Management’s United Therapeutics UTHR Stock Holding History

South Texas Money Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-186,519
Closed -$26.8M – 249
2016
Q4 		$26.8M Buy
186,519
+53,165
+40% +$6.79M 1.4% 25
2016
Q3 		$15.7M Buy
+133,354
New +$16M 0.87% 44

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

South Texas Money Management's UTHR Position: Q1 2017 in Review

South Texas Money Management sold out of United Therapeutics (UTHR) in Q1 2017, closing a stake of 186,519 shares — an estimated $26.8M sold.

South Texas Money Management first reported a position in UTHR in Q3 2016 and held it in 2 quarters. The position peaked at $26.8M in Q4 2016. 411 funds tracked by Wall St. Rank hold UTHR as of Q1 2017.

  • South Texas Money Management reported no remaining United Therapeutics position as of Q1 2017 after selling out during the quarter.
  • South Texas Money Management sold 186,519 United Therapeutics shares in Q1 2017, an estimated $26.8M.
  • South Texas Money Management first reported a position in United Therapeutics in Q3 2016 and held it in 2 quarters.
  • South Texas Money Management's United Therapeutics position peaked at $26.8M in Q4 2016.
  • 411 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2017.

Based on South Texas Money Management's 13F filing for Q1 2017, filed 10 May 2017.